Chronic thrombocytopenia with platelet transfusion refractoriness
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Chronic thrombocytopenia with platelet transfusion refractoriness
Exclusion criteria
Exclusion criteria: The following viral infection: Hepatic Virus B Hepatic Virus C Human Immunodeficiency Virus Human T-cell leukemia virus Human parvovirus B19 Cytomegalovirus Epstein-Barr virus West Nile Virus The following bacterial infection: Treponema pallidum Chlamydiaceae Genus Neisseria Mycobacterium Sepsis (including suspected case) Malignant neoplasm Severe or uncontrolled metabolic or endocrinal disorders Connective tissue diseases Hematologic diseases (other than chronic thrombocytopenia) Hepatic disorders Transmissible spongiform encephalopathy (including suspected case) Dementia or cognitive impairment Particular or genetic/hereditary disorders (including suspected case with familial history)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To examine the feasibility of platelet production and functionality in vitro between healthy- and patient-derived derivatives | — |
Secondary
| Measure | Time frame |
|---|---|
| To focus on the in vitro functional parameters | — |
Countries
Japan
Contacts
Center for iPS Cell Research and Application (CiRA), Kyoto University Department of Clinical Application